Intravitreal anti-vascular endothelial growth factor therapy for retinal diseases in Norway from 2011 to 2021: A combined registry and survey study.

Husum, Yngvil Solheim; Bråten, Ragnhild Haugli; Saether, Erik Magnus; Moe, Morten Carstens; Kristiansen, Ivar Sønbø; Jørstad, Øystein Kalsnes

Husum, Yngvil Solheim; Bråten, Ragnhild Haugli; Saether, Erik Magnus; Moe, Morten Carstens; Kristiansen, Ivar Sønbø; Jørstad, Øystein Kalsnes.

Afiliação

Husum YS; Department of Ophthalmology, Oslo University Hospital, Oslo, Norway.
Bråten RH; Faculty of Medicine, Institute for Clinical Medicine, University of Oslo, Oslo, Norway.
Saether EM; Oslo Economics, Oslo, Norway.
Moe MC; Oslo Economics, Oslo, Norway.
Kristiansen IS; Department of Ophthalmology, Oslo University Hospital, Oslo, Norway.
Jørstad ØK; Faculty of Medicine, Institute for Clinical Medicine, University of Oslo, Oslo, Norway.

Acta Ophthalmol ; 2023 Dec 09.

Article em En | MEDLINE | ID: mdl-38071435

Palavras-chave

Norway; anti-VEGF; intravitreal injection; registry; retinal disease; survey

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Acta Ophthalmol Assunto da revista: OFTALMOLOGIA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Noruega

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google